References
  1. Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses 2016; 10: 394–403.
  2. Costache C, Botan A, Mihaila RM, Colosi IA, Buksa SB, Chiorescu RM. Mixed Etiology COVID-19 Associated Pulmonary Aspergillosis (CAPA)—A Case Report and Brief Review of the Literature. Journal of Fungi. 2021 Oct; 7(10):877.
  3. Johnson AK, Ghazarian Z, Cendrowski KD, Persichino JG. Pulmonary aspergillosis and mucormycosis in a patient with COVID-19. Medical mycology case reports. 2021 Jun 1; 32:64-7.
  4. Moniz P, Brito S, Póvoa P. SARS-CoV-2 and cytomegalovirus co-infections—a case series of critically ill patients. Journal of Clinical Medicine. 2021 Jan; 10(13):2792.
  5. Jeannet R, Daix T, Formento R, Feuillard J, François B. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression. Intensive care medicine. 2020 Sep; 46:1769-71.
  6. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. The Lancet. 2003 Nov 29; 362(9398):1828-38.
  7. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Critical Care. 2009 Jun; 13(3):1-0.
  8. Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases. 2020 Nov 1; 71(9):2459-68.
  9. Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Research. 2020 Aug 1; 285:198005.
  10. Montrucchio G, Corcione S, Sales G, Curtoni A, De Rosa FG, Brazzi L. Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball. Journal of global antimicrobial resistance. 2020 Dec 1; 23:398-400.
  11. De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., Pappas, P.G., Maertens, J., Lortholary, O., Kauffman, C.A. and Denning, D.W., 2008. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clinical infectious diseases, 46(12), pp.1813-1821.
  12. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clinical infectious diseases. 2002 Apr 15; 34(8):1094-7.